Marketing Authorization Procedure and Their Requirements for Pharmaceutical Products in European Union
Abstract
Developing a new drug requires a great amount of research works in chemistry, manufacturing, controls, preclinical science and clinical trials. European Union (EU) is a hub of political and economic union of 28 member states (MS) and extensive amount of effort was spent by the EU Commission, the EU parliament, the European Medicines Agency (EMEA) and the national authorities in updating the EU regulatory environment for pharmaceuticals and granting marketing authorizations within the EU region. There are mainly three procedures by which a marketing authorization of pharmaceutical product in EU can be granted. Like 1. Centralized Procedure which is compulsory for any novel medicinal products and the subject to agreement by Committee on Proprietary Medicinal Products (CPMP), 2. Mutual Recognition Procedure (MRP) which commences only after a marketing authorization has been issued in any member state of EU, which then becomes the Reference Member State (RMS) and 3. Decentralized Procedure which came into force with the newly revised EU pharmaceutical Directive in November 2005 which is applicable in cases where an authorization does not yet exist in any of the EU Member States. However, Every EU country has their own registration process, which can be used by them when manufacturer wish to register their product in respective countries. However, if the European directive is completely implemented, the harmonization process appears difficult in consideration of the different social, political and economical characteristics of the different countries. Hence, the Main objective of this work is to understand the pharmaceutical product registration by different marketing procedures in European Union.
Keywords: European Union, National procedure, Centralized Procedure, Mutual Recognition Procedure, Decentralized Procedure
Downloads
Published
Issue
Section
License
Copyright Transfer and Declaration Form (Please compile this form, sign and send by e-mail and post)
Journal Title:
Title of the Paper:
Corresponding Author’s Information: Name: Address:
E-mail:
Contact Number: I
t is herein agreed that: The copyright to the above-listed unpublished and original article is transferred to STM Journals. This copyright transfer covers the exclusive right to reproduce and distribute the contribution, including reprints, translations, photographic reproductions, microform, electronic form (offline, online), or any other reproductions of similar nature. I/We declare that above manuscript is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere. I/ We warrant(s) that his/her/their contribution is original, except for such excerpts from copyrighted works as may be included with the permission of the copyright holder and author thereof, that it contains no libelous statements, and does not infringe on any copyright, trademark, patent, statutory right, or propriety right of others. I/We will not publish his/her/their above said contribution anywhere else without the prior written permission of the publisher unless it has been changed substantially.I/We also agree to the authorship of the article in the following order:Author(s) Name Signature(s)
1. ________________
2. _______________
_3. ________________
4. ________________
The author(s) agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal (comments if any to the editor can be added below).
